Anugerah 88 Logo
$2.94+0.01|(+0.34%)
52W H: 29.9852W L: 2.83Beta: 0.49

About Seres Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for MCRB?

The 52-week high is $29.98 and the 52-week low is $2.83.

What is the P/E ratio for MCRB?

The P/E ratio data is currently unavailable.

What is the dividend yield for MCRB?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -60.32%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -1192.94%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 3.04.

Analyst Recommendation Trends

Wall Street analyst consensus for MCRB over the last few months:

2026-09-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0

Latest MCRB News

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading live biotherapeutics company, today announced that on September 4, 2026, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate of 4,200 shares of its common stock to two new employees. These stock options are subject to the terms of the Seres Therapeutics, Inc. 2022 Emp

Yahoo9/8/2026

Microbiome Therapeutics Market Report 2026-2035 Featuring Profiles of Ferring Pharmaceuticals, Infant Bacterial Therapeutics, MaaT Pharma, Mikrobiomik, Seres Therapeutics, Vedanta Biosciences

Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics Market by Type of Product, Route of Administration, Target Indication, Therapeutic Area, End User and Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global microbiome therapeutics market is projected to increase from USD 0.6 billion in 2026 to USD 4.6 billion by 2035, registering a compound annual growth rate of 25.4% during the forecast period. Market expansion

Yahoo9/7/2026

Related Stocks (Peers)

Companies operating in similar sectors to MCRB:

BYSIABVCQNCXBIOQMCRBATYRCLCSSHPHGRDXRNAZ950160.KQ

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-17Brady Kelly-64$4.55$291
2026-08-17Shaff Eric D.-263$4.55$1,197
2026-08-17Henn Matthew R-81$4.55$369
2026-08-17DesRosier Thomas-82$4.55$373
2026-08-15Brady Kelly-91--
2026-08-15Brady Kelly-90--
2026-08-15Brady Kelly+181--
2026-08-15Shaff Eric D.-332--
2026-08-15Shaff Eric D.-390--
2026-08-15Shaff Eric D.+722--
2026-08-15Henn Matthew R-98--
2026-08-15Henn Matthew R-140--
2026-08-15Henn Matthew R+238--
2026-08-15DesRosier Thomas-112--
2026-08-15DesRosier Thomas-133--
2026-08-15DesRosier Thomas+245--
2026-07-08Rosiello Robert L.+6,500--
2026-07-08Berenson Stephen+6,500--
2026-07-08Henn Matthew R+25,000--
2026-07-08Thorell Marella+7,500--
2026-07-08Shaff Eric D.+6,500--
2026-07-08Brady Kelly+18,750--
2026-07-08DesRosier Thomas+7,500--
2026-07-08Graves Kurt+6,500--
2026-07-08Fraser Claire+6,500--
2026-07-08Ausiello Dennis A+6,500--
2026-07-08Kender Richard N+50,000--
2026-07-08Dere Willard H+6,500--
2026-07-01Berenson Stephen+7,508--
2026-07-01Rosiello Robert L.+7,508--
2026-07-01Ausiello Dennis A+7,508--
2026-05-18Shaff Eric D.-259$7.53$1,950
2026-05-18Brady Kelly-59$7.53$444
2026-05-18Henn Matthew R-77$7.53$580
2026-05-18DesRosier Thomas-79$7.53$595
2026-05-15Shaff Eric D.-331--
2026-05-15Shaff Eric D.-391--
2026-05-15Shaff Eric D.+722--
2026-05-15Brady Kelly-91--
2026-05-15Brady Kelly-89--
2026-05-15Brady Kelly+180--
2026-05-15Henn Matthew R-97--
2026-05-15Henn Matthew R-141--
2026-05-15Henn Matthew R+238--
2026-05-15DesRosier Thomas-111--
2026-05-15DesRosier Thomas-133--
2026-05-15DesRosier Thomas+244--
2026-03-04Brady Kelly+56,250--
2026-03-04Henn Matthew R+75,000--
2026-03-04Thorell Marella+22,500--
2026-03-04DesRosier Thomas+22,500--
2026-03-04Kender Richard N+150,000--
2026-02-15Young Teresa L.-98--
2026-02-15Young Teresa L.-133--
2026-02-15Young Teresa L.-75$8.47$635
2026-02-15Young Teresa L.+231--
2026-02-15Shaff Eric D.-333--
2026-02-15Shaff Eric D.-391--
2026-02-15Shaff Eric D.-259$8.47$2,194
2026-02-15Shaff Eric D.+723--
2026-02-15Henn Matthew R-98--
2026-02-15Henn Matthew R-141--
2026-02-15Henn Matthew R-89$8.47$754
2026-02-15Henn Matthew R+239--
2026-02-15DesRosier Thomas-111--
2026-02-15DesRosier Thomas-133--
2026-02-15DesRosier Thomas-78$8.47$661
2026-02-15DesRosier Thomas+244--
2025-11-15Young Teresa L.-98--
2025-11-15Young Teresa L.-132--
2025-11-15Young Teresa L.-3,998--
2025-11-15Young Teresa L.-1,042$17.3$18,027
2025-11-15Young Teresa L.+98--
2025-11-15Young Teresa L.+132--
2025-11-15Young Teresa L.+3,998--
2025-11-15Shaff Eric D.-331--
2025-11-15Shaff Eric D.-390--
2025-11-15Shaff Eric D.-217$17.3$3,754
2025-11-15Shaff Eric D.+331--
2025-11-15Shaff Eric D.+390--
2025-11-15Henn Matthew R-98--
2025-11-15Henn Matthew R-140--
2025-11-15Henn Matthew R-3,998--
2025-11-15Henn Matthew R-1,257$17.3$21,746
2025-11-15Henn Matthew R+98--
2025-11-15Henn Matthew R+140--
2025-11-15Henn Matthew R+3,998--
2025-11-15DesRosier Thomas-112--
2025-11-15DesRosier Thomas-132--
2025-11-15DesRosier Thomas-76$17.3$1,315
2025-11-15DesRosier Thomas+112--
2025-11-15DesRosier Thomas+132--